Hitachi And Redlen Technologies Announce Agreement On Joint Development
March 7, 2016
Saanichton, BC, — Hitachi Medical Corporation, a subsidiary of Hitachi, Ltd. (TSE:6501) and Redlen Technologies Inc., a Canadian technology company, today announced an agreement to jointly develop a direct conversion semiconductor x-ray detector module required for new photon counting computed tomography systems (PCCT), a promising next generation diagnostic medical imaging modality.
Hitachi has been focusing on the healthcare field as one of the Social Innovation Business, and has extensive expertise in healthcare total solutions which include medical diagnostic and clinical devices such as CT, MRI, particle beam therapy systems, and also informatics including medical service and platform. Redlen is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are used in the fields of medical imaging, security and nondestructive testing.
Author: Redlen Technologies
In the news
Yaletown Partners is proud to participate in a $20 million Series B financing round by crowdsourcing software company Thoughtexcha…
December 10, 2019
Yaletown is pleased to report that our portfolio company ThoughtWire was mentioned in an article from The Globe and Mail about glo…
December 6, 2019